临床儿科杂志 ›› 2015, Vol. 33 ›› Issue (6): 562-.doi: 10.3969 j.issn.1000-3606.2015.06.015

• 综合报道 • 上一篇    下一篇

红细胞免疫抗体引起的新生儿溶血病4 例报告

徐文皓1,向东2   

  1. 1. 上海交通大学附属第六人民医院( 上海 200233);2. 上海市血液中心( 上海 200051)
  • 收稿日期:2015-06-15 出版日期:2015-06-15 发布日期:2015-06-15
  • 通讯作者: 徐文皓 E-mail:13816284553@139.com

A report of four cases of hemolytic disease caused by red blood cell immune in neonates antibodies

XU Wenhao1,XIANG Dong2   

  1. 1. The Sixth People’s Hospital, Shanghai Jiaotong University, Shanghai 200233, China; 2 Department of Red Blood Cell Reference, Shanghai Blood Center, Shanghai 200051, China
  • Received:2015-06-15 Online:2015-06-15 Published:2015-06-15

摘要: 目的 探讨红细胞免疫抗体引起的新生儿溶血病病例的母婴实验室检测结果、临床表现及治疗。方法 回顾性分析4例红细胞免疫抗体引起的新生儿溶血病患儿及母亲产前相关实验室及临床资料。结果 4例患儿的母亲在孕期分别检测出IgG性质的红细胞抗E、抗D、抗Jkb及自身抗体;效价分别为16、2 048、1及16。患儿均足月分娩,但生后6 h~3 d出现不同程度的皮肤黄染,伴或不伴贫血。患儿红细胞放散试验发现存在与母体相同的抗体,效价分别为4、512、0及2。患儿均予光照治疗,2例重症患儿予换血及输血治疗,均预后良好。结论 孕妇产前免疫血液学检查有助于及早发现红细胞不规则抗体以评估胎儿及新生儿溶血病风险。

Abstract: Objective To investigate the laboratory findings, clinical manifestations and treatment in hemolytic disease caused by red cell immune antibodies in neonates. Methods The laboratory and clinical data from 4 cases of hemolytic disease of neonates caused by red cell immune antibodies were retrospectively analyzed. Results IgG antibody were detected in all mothers of 4 cases during pregnancy and they were anti-E, anti-D, anti-Jkb and the autoantibody with the titer being 16, 2048, 1 and 16 respectively. The four neonates were all full-term. The jaundice appeared 6 h to 3 d after birth with varying degrees of skin stained yellow, with or without anemia. Serology and elution test found the existence of antibody same as the one on their maternal red cells and the titer was 4, 512, 0, and 2, respectively. All neonates were treated by phototherapy. Two servere cases were also treated by whole blood exchange and red blood cells transfusion. The prognosis were good in all neonates. Conclusions Prenatal immune hematological tests facilitated early detection of irregular erythrocyte antibodies and thus assessment of the risk of hemolytic disease of the fetus and neonates.